Is CEVA (CEVA) Quietly Rewiring Its Physical AI Story Through Chery’s Global Supply Chain Deal?

• In recent days, CMA CGM announced a Memorandum of Understanding with its subsidiary CEVA Logistics and Chinese automaker Chery to support Chery’s international expansion across Europe, Asia-Pacific, Latin America, and the Middle East, covering finished vehicles, parts, and EV batteries.
• This tripartite agreement positions CEVA as a key logistics partner in the global automotive and EV supply chain, potentially deepening its exposure to higher-value, cross-regional transport and contract logistics services.
• Next, we’ll examine how CEVA’s role in Chery’s global supply chain could influence its existing investment narrative around Physical AI growth.

We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

CEVA Investment Narrative Recap

To own CEVA today, you generally have to believe its wireless, edge AI and “Physical AI” IP portfolio can translate into sustained licensing and royalty growth, despite current losses and margin pressure. The Chery logistics MoU does not directly affect CEVA, but it does underscore how Physical AI and automation themes are spreading into real-world supply chains, which could support sentiment around CEVA’s AI narrative. The main near term catalyst remains execution on new IP wins, while profitability and valuation look like key risks.

Among recent announcements, CEVA’s Q1 2026 update, highlighting stronger licensing revenue and new customer wins in Bluetooth and Wi Fi 6, feels most relevant. It shows the company is still adding design wins that could feed future royalties, an important counterweight to concerns about revenue concentration and intense R&D spend. How effectively CEVA turns these design wins into higher margin royalties will likely matter more than headline AI enthusiasm sparked by Physical AI coverage.

Yet behind the excitement around Physical AI, there is a separate risk investors should be aware of, around CEVA’s heavy dependence on a few key customers and whether...

Read the full narrative on CEVA (it's free!)

CEVA's narrative projects $160.2 million revenue and $6.7 million earnings by 2029. This requires 12.5% yearly revenue growth and a $18.5 million earnings increase from -$11.8 million today.

Uncover how CEVA's forecasts yield a $43.12 fair value, a 13% downside to its current price.

Exploring Other Perspectives

While the Chery news highlights growing Physical AI themes, the most bearish analysts were assuming only about US$157.2 million revenue and US$5.0 million earnings by 2029, so their far more cautious view on CEVA’s licensing upside may need revisiting in light of new developments.

Explore 6 other fair value estimates on CEVA - why the stock might be worth as much as $43.12!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CEVA research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free CEVA research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CEVA's overall financial health at a glance.

Seeking Other Investments?

Our top stock finds are flying under the radar-for now. Get in early:

• Find 45 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com